Revenue: The sum of all revenue fields included for a company's operating activities.
Akero Therapeutics, Inc. (AKRO) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-53.34M |
|
-- |
|
-- |
|
$59.95M |
|
$-59.95M |
|
$6.61M |
|
$-53.34M |
|
$-53.34M |
|
$-53.34M |
|
$-53.34M |
|
$-53.34M |
|
$-53.34M |
|
$-59.95M |
|
$-62.76M |
|
59.31M |
|
59.31M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$911.28M |
|
$0.02M |
|
$0.96M |
|
$912.24M |
|
$30.26M |
|
$34.98M |
|
$35.73M |
|
$65.99M |
|
$846.25M |
|
$846.25M |
|
$846.25M |
|
69.15M |
|
| Cash Flow Statement Financials | |
$-35.14M |
|
$57.85M |
|
$366.94M |
|
$234.21M |
|
$623.85M |
|
$389.65M |
|
$7.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
30.12 |
|
-- |
|
-- |
|
0.04 |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.30% |
|
-6.30% |
|
-5.85% |
|
-6.05% |
|
$12.24 |
|
$-0.59 |
|
$-0.59 |
|